Records containing: Overweight
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-01-20Reversing the Negative Cardiovascular Effects of Weight (ReNEW) Clinic Cohort Study
-
CLINICAL_TRIALS study record update · 2026-01-20A Multiple-Ascending Dose Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of LY3537031 in Overweight and Obese Participants and Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2026-01-20A Phase 2 Randomized, Placebo-controlled, Double-blind, Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2026-01-16A Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3841136 Monotherapy, and LY3841136 in Combination With Tirzepatide, in Japanese Participants With Obesity or Overweight
-
CLINICAL_TRIALS study record update · 2026-01-15A Randomized, Double-Blind, Phase 2 Trial of Once-Weekly Petrelintide Compared With Placebo in Participants With Overweight or Obesity and Type 2 Diabetes
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-15Comparison of VitalPLANT and Helichrysum Italicum Infusions Effects on the Components of Metabolic Syndrome in Adults
-
CLINICAL_TRIALS study record update · 2026-01-15A Two-Part First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Subcutaneous Doses of GUB014295 in Lean to Overweight or Obese But Otherwise Healthy Men and Women
-
CLINICAL_TRIALS study record update · 2026-01-14Wegovy® (Semaglutide 2.4 mg) Pregnancy Registry Study: A Prospective Cohort Study to Investigate Safety Outcomes of Exposure to Wegovy During Pregnancy
-
CLINICAL_TRIALS study record update · 2026-01-14Wegovy® (Semaglutide 2.4 mg) Database Study: A Population-based Cohort Study to Investigate Safety Outcomes of Exposure to Wegovy During Pregnancy
-
CLINICAL_TRIALS study record update · 2026-01-13Efficacy and Safety of Semaglutide 2.4 mg Once-weekly in Adults With Overweight and Obesity
-
CLINICAL_TRIALS study record update · 2026-01-12Promotion of Successful Weight Management in Overweight and Obese Veterans
-
CLINICAL_TRIALS study record update · 2026-01-12Expanding the Family Check-Up in Early Childhood to Promote Cardiovascular Health of Mothers and Young Children (ENRICH)
-
CLINICAL_TRIALS study record update · 2026-01-12A Phase 3, Randomized, Double-blind, Placebo-Controlled Study to Investigate the Effect of Tirzepatide on the Reduction of Morbidity and Mortality in Adults With Obesity
-
CLINICAL_TRIALS study record update · 2026-01-08An Investigation of the Effect of Cagrilintide and Semaglutide Combination Treatment (CagriSema) on Appetite and Functional Brain Activity in People With Overweight or Obesity
-
CLINICAL_TRIALS study record update · 2026-01-06Cardiometabolic Effects of Increasing Non-Exercise Physical Activity Combined With Aerobic Exercise in Overweight Young Women
-
CLINICAL_TRIALS study record update · 2025-12-30A Phase 1, Randomized, Open-label, Parallel-group, Drug-drug Interaction Study to Evaluate the Effect of Antiemetic Medication on the Pharmacokinetics of AMG 133 in Participants Living With Overweight or Obesity
-
CLINICAL_TRIALS study record update · 2025-12-24Feasibility Study of an Intensive Nutrition Therapy Program for Improvement of Obesity and Diabetes in a Low-income Population
-
CLINICAL_TRIALS study record update · 2025-12-23Investigation of Pharmacokinetic Properties of Single Doses of NNC0662-0419 in Japanese, Chinese and Non-Asian Participants Living With Overweight or Obesity
-
CLINICAL_TRIALS study record update · 2025-12-22A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Orforglipron Once Daily Versus Placebo for Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
-
CLINICAL_TRIALS study record update · 2025-12-18A Phase 3, Randomized, Double-blind, Double-dummy, Parallel-group, Active Drug and Placebo-controlled, Safety, Efficacy and Superiority of Sibutramine IR/Topiramate XR in Overweight Adults With Comorbidities/Obesity
-
CLINICAL_TRIALS study record update · 2025-12-17Optimization of Chrononutrition to Reduce the Risk of Disease in Shift Workers - The SHIFT Study
-
CLINICAL_TRIALS study record update · 2025-12-17Fixed Versus Variable Energy Reduction During Behavioral Obesity Treatment
-
CLINICAL_TRIALS study record update · 2025-12-17Effectiveness and Cost-Effectiveness of Fully-Automated Digital vs. Human Coach-Based Diabetes Prevention Programs
-
CLINICAL_TRIALS study record update · 2025-12-15A Randomized, Double-blind, Placebo-controlled, Dose-escalation Phase I Study on the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-2906 Injection in Healthy Subjects With a Single Dose and in Obese Patients With Multiple Doses
-
CLINICAL_TRIALS study record update · 2025-12-15A Study Investigating Safety, Tolerability and Efficacy of Once-weekly NNC0662-0419 in Participants Living With Overweight or Obesity